NASDAQ:CMMB

Chemomab Therapeutics Stock Insider Trading

etoro logo Buy CMMB
*Your capital is at risk
$1.72
-0.0200 (-1.15%)
At Close: Jun 03, 2026

Chemomab Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 1.33M and sold 751.86K CMMB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 1.33M shares
Sell 751.86K shares
90% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Mar 16, 2023
Buy
Option to Purchase American Depositary Shares
A-Award
Nicaise Claude
Director
Director 6 857
Value: $11.1K
Jan 03, 2023
Sell
American Depository Shares
S-Sale
Orbimed Israel Gp Ltd.
Director
Director 266 376
Value: $889.7K
Jan 03, 2023
Sell
American Depository Shares
S-Sale
Orbimed Israel Gp Ltd.
Director
Director 70 524
Value: $318.1K
Jan 03, 2023
Sell
American Depositary Shares
S-Sale
Mor George Adi
Chief Scientific Officer
Officer 7 700
Value: $38.7K
Jan 03, 2023
Sell
American Depositary Shares
S-Sale
Mor George Adi
Chief Scientific Officer
Officer 6 100
Value: $30.7K
Jan 03, 2023
Sell
American Depository Shares
S-Sale
Orbimed Israel Gp Ltd.
Director
Director 266 376
Value: $889.7K
Jan 03, 2023
Sell
American Depository Shares
S-Sale
Orbimed Israel Gp Ltd.
Director
Director 70 524
Value: $318.1K
Jan 03, 2023
Sell
American Depositary Shares
S-Sale
Mor George Adi
Chief Scientific Officer
Officer 7 700
Value: $38.7K
Jan 03, 2023
Sell
American Depositary Shares
S-Sale
Mor George Adi
Chief Scientific Officer
Officer 6 100
Value: $30.7K
Nov 08, 2022
Buy
Option to Purchase American Depositary Shares
A-Award
Fatal Sigal
Chief Financial Officer
C-Suite Officer 29 400
Value: $62.0K
Nov 08, 2022
Buy
Option to Purchase American Depositary Shares
A-Award
Fatal Sigal
Chief Financial Officer
C-Suite Officer 29 400
Value: $62.0K
Jun 16, 2022
Buy
Option to Purchase American Depositary Shares
A-Award
Quigley Jill M.
Director
Director 13 640
Value: $44.3K
Jun 16, 2022
Buy
Option to Purchase American Depositary Shares
A-Award
Quigley Jill M.
Director
Director 13 640
Value: $44.3K
Mar 07, 2022
Buy
Option to Purchase American Depositary Shares
A-Award
Darvish Nissim
Director
Director 6 820
Value: $24.1K
Mar 07, 2022
Buy
Option to Purchase American Depositary Shares
A-Award
Darvish Nissim
Director
Director 6 820
Value: $24.1K
Nov 11, 2021
Buy
Option to Purchase American Depositary Shares
A-Award
Fatal Sigal
Chief Financial Officer
C-Suite Officer 35 600
Value: $349.9K
Nov 11, 2021
Buy
Option to Purchase American Depositary Shares
A-Award
Fatal Sigal
Chief Financial Officer
C-Suite Officer 35 600
Value: $349.9K
Apr 19, 2021
Buy
Option to Purchase American Depositary Shares
A-Award
Darvish Nissim
Director
Director 11 884
Value: $324.0K
Apr 19, 2021
Buy
Option to Purchase American Depositary Shares
A-Award
Darvish Nissim
Director
Director 11 884
Value: $324.0K
Mar 15, 2018
Buy
Option to Purchase American Depositary Shares
A-Award
Mor George Adi
Chief Scientific Officer
Officer 131 698
Value: $0
Mar 15, 2018
Buy
Option to Purchase American Depositary Shares
A-Award
Mor George Adi
Chief Scientific Officer
Officer 131 698
Value: $0
Oct 28, 2016
Buy
Option to Purchase American Depositary Shares
A-Award
Darvish Nissim
Director
Director 10 123
Value: $8K
Oct 28, 2016
Buy
Option to Purchase American Depositary Shares
A-Award
Darvish Nissim
Director
Director 10 123
Value: $8K
Oct 28, 2016
Buy
Option to Purchase American Depositary Shares
A-Award
Mor George Adi
Chief Scientific Officer
Officer 33 725
Value: $0
Oct 28, 2016
Buy
Option to Purchase American Depositary Shares
A-Award
Mor George Adi
Chief Scientific Officer
Officer 33 725
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CHEMOMAB THERAPEUTICS LTD.
Chemomab Therapeutics
Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). The company was formerly known as Anchiano Therapeutics Ltd. and cha...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE